NASDAQ Companies

MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing […]

MATTOON, Ill., July 30, 2020 (GLOBE NEWSWIRE) — First Mid Bancshares, Inc. (NASDAQ: FMBH) (the “Company”) today announced its financial […]

GLEN HEAD, N.Y., July 30, 2020 (GLOBE NEWSWIRE) — The First of Long Island Corporation (Nasdaq: FLIC), the parent company […]

WATERTOWN, Mass., July 30, 2020 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking […]

Company delivered stable revenue and Adjusted EBITDA growth;Substantially increased free cash flow; demonstrating continued progress on deleveragingSecond Quarter HighlightsRevenue totaled […]

SANTA CLARA, Calif., July 30, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of […]

WALL, N.J., July 30, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access […]

AC Immune is one of three winners sharing USD 10 million through The Michael J. Fox Foundation Ken Griffin Alpha-synuclein […]

CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) — AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced […]

– Rilonacept pivotal Phase 3 trial in recurrent pericarditis met statistical significance for primary and all major secondary efficacy endpoints; sBLA […]